F Straßheimer

432 total citations
14 papers, 232 citations indexed

About

F Straßheimer is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, F Straßheimer has authored 14 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in F Straßheimer's work include CAR-T cell therapy research (10 papers), Immune Cell Function and Interaction (8 papers) and Glioma Diagnosis and Treatment (5 papers). F Straßheimer is often cited by papers focused on CAR-T cell therapy research (10 papers), Immune Cell Function and Interaction (8 papers) and Glioma Diagnosis and Treatment (5 papers). F Straßheimer collaborates with scholars based in Germany and United Kingdom. F Straßheimer's co-authors include Michael C. Burger, Torsten Tonn, Winfried S. Wels, Joachim P. Steinbach, Patrick N. Harter, Congcong Zhang, A Romański, Christian Senft, Lisa Sevenich and Tijna Alekseeva and has published in prestigious journals such as British Journal of Cancer, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

F Straßheimer

14 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Straßheimer Germany 5 160 143 53 50 28 14 232
Lukas Rindlisbacher Switzerland 4 176 1.1× 129 0.9× 43 0.8× 76 1.5× 69 2.5× 7 262
Giulia Cattaneo United States 5 133 0.8× 72 0.5× 38 0.7× 40 0.8× 50 1.8× 15 178
Chujun Zhao China 6 145 0.9× 145 1.0× 45 0.8× 82 1.6× 19 0.7× 6 279
William Day United Kingdom 5 110 0.7× 104 0.7× 64 1.2× 67 1.3× 25 0.9× 7 228
Alexandria Van Scoyk United States 7 146 0.9× 93 0.7× 36 0.7× 100 2.0× 29 1.0× 8 249
Céline Yacoub Maroun Switzerland 7 153 1.0× 205 1.4× 25 0.5× 121 2.4× 21 0.8× 8 338
Monika A. Eiva United States 4 185 1.2× 195 1.4× 12 0.2× 72 1.4× 50 1.8× 6 290
Jaquelyn T. Zoine United States 9 203 1.3× 116 0.8× 25 0.5× 79 1.6× 48 1.7× 12 266
Berwini Endaya Australia 7 85 0.5× 60 0.4× 62 1.2× 113 2.3× 20 0.7× 10 237
Valeria Governa Switzerland 8 165 1.0× 180 1.3× 23 0.4× 69 1.4× 39 1.4× 16 318

Countries citing papers authored by F Straßheimer

Since Specialization
Citations

This map shows the geographic impact of F Straßheimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Straßheimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Straßheimer more than expected).

Fields of papers citing papers by F Straßheimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Straßheimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Straßheimer. The network helps show where F Straßheimer may publish in the future.

Co-authorship network of co-authors of F Straßheimer

This figure shows the co-authorship network connecting the top 25 collaborators of F Straßheimer. A scholar is included among the top collaborators of F Straßheimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Straßheimer. F Straßheimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Straßheimer, F, Jadranka Macas, Tijna Alekseeva, et al.. (2025). CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma. British Journal of Cancer. 132(9). 849–860. 6 indexed citations
2.
Straßheimer, F, Hans Urban, Stephanie Hehlgans, et al.. (2024). Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1. Cell Death Discovery. 10(1). 379–379. 7 indexed citations
3.
Reindl, Leonhard, F Straßheimer, Amy K. Kiefer, et al.. (2023). P06.10.A CAR-ENGINEERED PRIMARY NK CELLS SHOW PROMISING EFFECTS AS TARGETED THERAPY AGAINST EGFR-POSITIVE GLIOBLASTOMA. Neuro-Oncology. 25(Supplement_2). ii47–ii47. 1 indexed citations
4.
Elmshäuser, Sabrina, F Straßheimer, Michael Wanzel, et al.. (2022). Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase. Molecular Cancer. 21(1). 191–191. 2 indexed citations
5.
6.
Straßheimer, F, Jasmin Röder, Tijna Alekseeva, et al.. (2022). AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma. OncoImmunology. 11(1). 2127508–2127508. 36 indexed citations
7.
Straßheimer, F, Torsten Tonn, Joachim P. Steinbach, et al.. (2021). OS06.2A Local immunotherapy of glioblastoma via AAV-mediated gene transfer of checkpoint inhibitors in combination with CAR-NK cells. Neuro-Oncology. 23(Supplement_2). ii8–ii9. 1 indexed citations
8.
Straßheimer, F, Tijna Alekseeva, Jadranka Macas, et al.. (2021). OS12.6.A Combination therapy of CAR-NK-cells and anti-PD-1 results in high efficacy against advanced-stage glioblastoma in a syngeneic mouse model and induces protective anti-tumor immunity in vivo. Neuro-Oncology. 23(Supplement_2). ii15–ii15. 3 indexed citations
9.
10.
Luger, Anna‐Luisa, Nadja I. Lorenz, Hans Urban, et al.. (2020). Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death. Cancers. 12(8). 2144–2144. 8 indexed citations
11.
12.
Burger, Michael C., Congcong Zhang, Patrick N. Harter, et al.. (2019). CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy. Frontiers in Immunology. 10. 2683–2683. 159 indexed citations
13.
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lukas Rindlisbacher Breakdown of academic impact, for papers by Giulia Cattaneo Breakdown of academic impact, for papers by Chujun Zhao Breakdown of academic impact, for papers by William Day Breakdown of academic impact, for papers by Alexandria Van Scoyk Breakdown of academic impact, for papers by Céline Yacoub Maroun Breakdown of academic impact, for papers by Monika A. Eiva Breakdown of academic impact, for papers by Jaquelyn T. Zoine Breakdown of academic impact, for papers by Berwini Endaya Breakdown of academic impact, for papers by Valeria Governa
Rankless by CCL
2026